Last reviewed: June 25, 2026

Last updated: June 25, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide belongs to a class of medications called GLP-1 receptor agonists, originally developed to manage type 2 diabetes but now widely used for sustainable weight loss. Clinical trials show participants lose an average of 15% of body weight over one year with consistent use and lifestyle support. PlexusDx delivers compounded semaglutide injections from licensed 503A pharmacies to all 50 states without insurance requirements, starting at $149 per month.

How Semaglutide Injections Work for Weight Loss

Semaglutide activates GLP-1 receptors in your brain's appetite centers and slows stomach emptying, helping you feel fuller longer and reducing overall food intake. The medication also stabilizes blood sugar levels, which reduces energy crashes and cravings that typically sabotage weight loss efforts. This dual mechanism—appetite suppression plus metabolic improvement—addresses the biological roots of weight gain rather than relying on willpower alone.

Weekly injections deliver steady hormone signaling throughout your body, creating consistent appetite control without the fluctuations that come with daily oral medications. Most people report noticing reduced hunger within 3–5 days of their first injection, though full therapeutic benefits develop over 4–8 weeks as your body adjusts. PlexusDx personalizes your injection schedule and starting dose based on your health history and genetic risk factors.

Understanding Semaglutide Dosing and Titration

Semaglutide treatment begins at a low dose to minimize side effects, then increases gradually over several weeks until you reach an effective maintenance level for your body. This titration phase typically lasts 4–5 months, with dose increases occurring every 4 weeks as your tolerance improves. Your dose may need to go up. Your price won't—PlexusDx keeps monthly costs flat regardless of dose adjustments, removing financial barriers to optimized therapy.

Standard titration follows a progression designed to balance results with tolerability: you start at 0.25 mg, then advance to 0.5 mg, 1.0 mg, 1.7 mg, and potentially 2.4 mg based on individual response and side effect experience. Approximately 75% of patients benefit most from maintenance doses between 1.7 and 2.4 mg weekly. PlexusDx monitors your progress through regular telehealth check-ins to ensure your dose matches your personal weight loss goals and side effect tolerance.

Genetic Testing for Personalized Semaglutide Response

Not everyone responds to semaglutide equally—genetic variations in appetite and metabolic pathways influence how effectively the medication suppresses your hunger signals and weight regain risk. PlexusDx offers the Precision Peptide Genetic Test, a peptide-pathway analysis that identifies your unique genetic variants in GLP1R rs6923761, GIPR rs1800437, FTO rs9939609, and MC4R rs17782313, among 45 other obesity-related genes. This test maps 14 biological pathways and 150+ genetic insights to predict your medication responsiveness before investing time and money.

Knowing your genetic profile helps PlexusDx clinicians choose the right starting dose, anticipate your likely results, and decide whether semaglutide alone or a dual-compound protocol like GLP-Squared may serve you better. The Precision Peptide Genetic Test is available as a $99 add-on after your first month of treatment, giving you data-driven confidence that your therapy matches your biology. Patients with favorable genetic markers typically see 20–25% weight loss, while those with less responsive profiles may combine semaglutide with tirzepatide for enhanced outcomes.

Managing Side Effects and Setting Realistic Expectations

The most common side effects—mild nausea, reduced appetite (which is therapeutic), and occasional constipation—peak during dose increases and typically fade within 1–2 weeks as your body adapts. Staying hydrated, eating small frequent meals, and taking fiber supplements addresses these effects in most patients without stopping treatment. Fewer than 10% of people discontinue semaglutide due to intolerable side effects, and PlexusDx clinicians can adjust dosing or explore alternative compounds if problems persist.

Weight loss happens gradually—expect 1–2 pounds per week during the first 3 months, then a slower but steady decline as your body reaches a new metabolic equilibrium around month 6. Total weight loss typically ranges from 15% to 22% of starting body weight over one year with consistent injections and moderate lifestyle changes. PlexusDx coordinates with your personal health coach to reinforce nutrition and movement habits that amplify medication effects and prevent regain after treatment ends.

Cost, Access, and Insurance at PlexusDx

PlexusDx compounded semaglutide injections start at $149 per month across three commitment tiers, with no insurance required, no membership fees, and full HSA/FSA eligibility. Compounded medications from licensed 503A pharmacies cost 40–60% less than brand-name alternatives while maintaining identical pharmaceutical quality and potency. PlexusDx serves all 50 states with direct-to-home delivery, meaning you receive your weekly injections within days of enrollment without navigating prior authorizations or insurance denials.

Payment flexibility includes monthly, quarterly, and annual commitment options—higher upfront commitments offer modest savings but remain optional. Initial consultations are included in your first month's fee, so you begin treatment immediately after medical clearance. PlexusDx also offers oral semaglutide ($249/mo) and the dual-compound GLP-Squared injection ($249/mo) for patients who prefer alternatives or need faster results with tirzepatide's additional GIP-receptor activation.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How quickly will I lose weight on semaglutide injections?

Most patients notice reduced hunger within 3–5 days and begin losing 1–2 pounds per week by week 3–4 of treatment. Significant weight loss (10+ pounds) typically appears within 8–12 weeks as your dose reaches therapeutic levels. Individual results vary based on genetics, diet adherence, and exercise, but PlexusDx's Precision Peptide Genetic Test can predict your expected response rate before starting treatment.

Is compounded semaglutide from PlexusDx as effective as brand-name Wegovy?

Yes—PlexusDx sources all medications from licensed 503A compounding pharmacies that meet FDA manufacturing standards and use identical pharmaceutical-grade semaglutide as branded versions. Clinical efficacy and safety profiles are equivalent, with the main difference being cost: compounded semaglutide starts at $149/mo versus $900–$1,500/mo for brand-name injections without insurance.

What happens if semaglutide alone isn't giving me the results I want?

PlexusDx offers tirzepatide injections ($249/mo), which activates both GLP-1 and GIP receptors for 25–30% greater weight loss than semaglutide alone, or GLP-Squared dual-compound injections ($249/mo) combining semaglutide and tirzepatide in a single weekly shot. Your PlexusDx clinician can switch protocols at any time based on progress and genetic testing insights.

Are there serious side effects I should worry about with semaglutide?

Semaglutide is well-tolerated in clinical trials with mild, temporary side effects (nausea, constipation, reduced appetite) that fade within 1–2 weeks. Rare serious effects include pancreatitis, thyroid concerns (avoid if you have medullary thyroid cancer history), and dehydration—which is why PlexusDx requires an initial health screening and ongoing telehealth monitoring. Fewer than 10% of patients stop treatment due to side effects.

Will the Precision Peptide Genetic Test predict if semaglutide will work for me?

The test identifies your genetic variants in GLP1R, GIPR, FTO, and MC4R pathways that influence appetite regulation and weight-loss medication responsiveness. Patients with favorable genetic profiles typically lose 20–25% body weight, while those with less responsive variants may benefit more from dual-compound protocols like GLP-Squared. The $99 test (available after your first month) provides personalized data to optimize your therapy and realistic goal-setting.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves